KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Receivables - Other: 2019-2025

  • Xenon Pharmaceuticals' Receivables - Other was N/A to $812,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $812,000, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is N/A change from last year.
  • Xenon Pharmaceuticals' Receivables - Other amounted to $812,000 in Q3 2025, which was down 25.98% from $1.1 million recorded in Q2 2025.
  • Xenon Pharmaceuticals' 5-year Receivables - Other high stood at $1.5 million for Q4 2024, and its period low was $812,000 during Q3 2025.
  • For the 2-year period, Xenon Pharmaceuticals' Receivables - Other averaged around $1.1 million, with its median value being $1.1 million (2025).